Minimally invasive skin biopsy test for phosphorylated alpha-synuclein aids early Parkinson's diagnosis, per JAMA study.
A minimally invasive skin biopsy test, examining phosphorylated alpha-synuclein (P-SYN), could aid in early diagnosis of Parkinson's disease and related disorders, according to research published in the Journal of the American Medical Association. The study found that 93% of those with Parkinson's had a positive skin biopsy for P-SYN when compared to controls, offering hope for early diagnosis and accelerating drug development for these conditions.
March 20, 2024
10 Articles